Viewing nowGlimel Tablet 2mg (Glimepiride)
Glimepiride 2mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

MFDS item code 200300144 · Notified 2003.12.13 · Insurance code 642500170
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used in conjunction with dietary and exercise therapy to improve blood sugar control in patients with type 2 diabetes. It can be administered alone, and in cases where blood sugar control is difficult, it can be used in combination with other hypoglycemic agents such as insulin or metformin. This helps effectively manage blood sugar and improve diabetes symptoms.
Adjust the dose individually for each patient. Swallow whole without chewing, with at least 1/2 cup of water. This medication is taken orally once daily. Take it before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medication. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, little additional benefit is seen with doses above 4 mg, although some patients have achieved better metabolic control with doses increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider using insulin or another oral antidiabetic medication in combination. 2) Subsequent dose adjustment As diabetes control improves during treatment, the patient's need for this medication may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered in the event of weight loss, changes in lifestyle, or other factors that may increase the risk of hypoglycemia or hyperglycemia. 3) Switching from another oral glucose-lowering medication to this medication There is no exact dose equivalence between this medication and other oral glucose-lowering medications. When switching from another oral glucose-lowering medication to this medication, it is recommended that the method described under Initial dose be followed. That is, start with 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previous medication should be taken into account. 4) Dose monitoring While taking this medication, blood glucose and/or urine glucose levels should be measured regularly. Regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia is promptly controlled by consuming sugar immediately. Hypoglycemia may recur even after it has been successfully managed initially during treatment with sulfonylureas. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization may sometimes be necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medication and insulin is used in patients with secondary failure, and should be used when fasting blood glucose (FBG) is above 150 mg/dL. Administer 8 mg of this medication once daily with the first meal. Start insulin at a low dose and increase it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose daily whenever possible. Insulin dosage should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medication, adding metformin may be considered. Clinical information has been published on combination therapy with metformin and other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medication is used in combination with metformin, the desired blood glucose level can be achieved by adjusting the dose of each medication. However, efforts should be made to determine the minimum effective dose of each medication for blood glucose control. There is a risk of hypoglycemia with concomitant use of this medication and metformin, and the risk may increase. Appropriate precautions should be taken.
This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or in a state of coma. Additionally, it should not be administered to patients allergic to this medication or its components or those with severe liver or kidney impairment. Women who are pregnant or breastfeeding should not take this medication, and special caution is needed in cases of severe infections or around the time of surgery, as well as in patients with gastrointestinal issues. Patients with hereditary lactose intolerance should also avoid this medication. There is a high risk of hypoglycemia during the early stages of treatment, so special care should be taken to monitor elderly patients, those with poor nutritional status or irregular eating habits, and those with impaired kidney or liver function. Symptoms of hypoglycemia may occur, so patients and their families should be well-informed about the signs and management of hypoglycemia, and dosage adjustment may be necessary if there is a risk of hypoglycemia. This medication may cause various side effects, including hypoglycemia, visual disturbances, gastrointestinal issues, liver dysfunction, blood disorders, and allergic reactions, so if any abnormal symptoms occur, consult a physician immediately. To manage blood sugar levels, dietary therapy, exercise therapy, and weight management are essential in conjunction with this medication, and regular monitoring of blood sugar and liver function tests is required during treatment. There are many interactions with other medications, so be sure to inform healthcare providers when taking other medications, and adjustments may be necessary. Women who are pregnant or breastfeeding are advised to use insulin therapy instead of this medication, and the safety in children under 18 has not been established. In elderly patients, caution must be exercised in determining the medication dosage due to decreased kidney function. In the case of overdose, severe hypoglycemia may occur, requiring immediate emergency treatment, and it should be kept out of reach of children.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or activity, depression, confusion, language disorders, aphasia, visual impairment, tremors, incomplete paralysis, sensory disturbances, dizziness, weakness, loss of self-control, temporary mental confusion, convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and moist skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, biliary secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, neutropenia, agranulocytosis, pancytopenia, itching, hives, rash, shortness of breath, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disorders, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial edema, erectile dysfunction, flushing, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. It is recommended to maintain the storage temperature between 1 degree and 30 degrees Celsius at room temperature. This will help to preserve the effectiveness of the medication for a longer period.
This medication is a green rectangular tablet.
30 tablets/bottle, 100 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.